Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4777176
Max Phase: Preclinical
Molecular Formula: C30H26O12
Molecular Weight: 578.53
Molecule Type: Unknown
Associated Items:
ID: ALA4777176
Max Phase: Preclinical
Molecular Formula: C30H26O12
Molecular Weight: 578.53
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(/C=C/c1ccc(O)c(O)c1)OC[C@H]1O[C@@H](Oc2ccc3c(=O)c(-c4ccc(O)cc4)coc3c2)[C@H](O)[C@@H](O)[C@@H]1O
Standard InChI: InChI=1S/C30H26O12/c31-17-5-3-16(4-6-17)20-13-39-23-12-18(7-8-19(23)26(20)35)41-30-29(38)28(37)27(36)24(42-30)14-40-25(34)10-2-15-1-9-21(32)22(33)11-15/h1-13,24,27-33,36-38H,14H2/b10-2+/t24-,27-,28+,29-,30-/m1/s1
Standard InChI Key: FSTRESCBLHTEBP-NSVJHVEFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 578.53 | Molecular Weight (Monoisotopic): 578.1424 | AlogP: 2.02 | #Rotatable Bonds: 7 |
Polar Surface Area: 196.35 | Molecular Species: NEUTRAL | HBA: 12 | HBD: 6 |
#RO5 Violations: 3 | HBA (Lipinski): 12 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 8.77 | CX Basic pKa: | CX LogP: 2.89 | CX LogD: 2.87 |
Aromatic Rings: 4 | Heavy Atoms: 42 | QED Weighted: 0.11 | Np Likeness Score: 1.40 |
1. Zhang M,Zhang Y,Huang Q,Duan H,Zhao G,Liu L,Li Y. (2021) Flavonoids from Sophora alopecuroides L. improve palmitate-induced insulin resistance by inhibiting PTP1B activity in vitro., 35 [PMID:33412152] [10.1016/j.bmcl.2021.127775] |
Source(1):